Spinal radiosurgery--efficacy and safety after prior conventional radiotherapy
- PMID: 22177519
- PMCID: PMC3264666
- DOI: 10.1186/1748-717X-6-173
Spinal radiosurgery--efficacy and safety after prior conventional radiotherapy
Abstract
Background: Conventional external beam radiotherapy is a standard procedure for treatment of spinal metastases. In case of progression spinal cord tolerance limits further radiotherapy in pre-irradiated areas. Spinal stereotactic radiotherapy is a non-invasive option to re-treat pre-irradiated patients. Nevertheless, spinal radiosurgery results in relevant dose deposition within the myelon with potential toxicity. Aim of the study was to retrospectively analyse the efficacy and feasibility for salvage radiosurgery of spinal metastases.
Methods: During a period of 4 years (2005-2009) 70 lesions in 54 patients were treated in 60 radiosurgery sessions and retrospectively analysed. Clinical (pain, sensory and motor deficit) and radiological (CT/MRI) follow-up data were collected prospectively after radiosurgery. Pain - as main symptom - was classified by the Visual Analogue Scale (VAS) score. Every patient received single session radiosurgery after having been treated first-line with conventionally fractionated radiotherapy. Kaplan-Meier method and life tables were used to analyse freedom from local failure and overall survival.
Results: At a median follow-up of 14.5 months the actuarial rates of freedom from local failure at 6/12/18 months were 93%, 88% and 85%, respectively. The median radiosurgery dose was 1 × 18 Gy (range 10-28 Gy) to the median 70% isodose. The VAS score of patients with pain (median 6) dropped significantly (median 4, p = 0.002). In 6 out of 7 patients worse sensory or motor deficit after SRS was caused by local or distant failures (diagnosed by CT/MRI). One patient with metastatic renal cell carcinoma developed a progressive complete paraparesis one year after the last treatment at lumbar level L3. Due to multiple surgery and radiosurgery treatments at the lumbar region and further local progression, the exact reason remained unclear. Apart from that, no CTC grade III or higher toxicity has been observed.
Conclusions: By applying spinal radiosurgery relevant radiation doses can be limited to small parts of the myelon. This prevents myelopathic side effects and makes it an effective and safe treatment option for well-suited patients. Especially for previously irradiated patients with local failure or pain salvage SRS represents a valuable treatment option with high local control rates, low toxicity and significant pain reduction.
Figures



Similar articles
-
Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.J Neurosurg Spine. 2016 Nov;25(5):646-653. doi: 10.3171/2016.4.SPINE151523. Epub 2016 Jun 24. J Neurosurg Spine. 2016. PMID: 27341054
-
Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord.Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):499-506. doi: 10.1016/j.ijrobp.2009.07.1727. Epub 2010 Feb 3. Int J Radiat Oncol Biol Phys. 2010. PMID: 20133079
-
Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?Technol Cancer Res Treat. 2015 Apr;14(2):159-67. doi: 10.7785/tcrt.2012.500411. Epub 2014 Nov 21. Technol Cancer Res Treat. 2015. PMID: 24502552
-
The role of stereotactic body radiotherapy and stereotactic radiosurgery in the re-irradiation of metastatic spinal tumors.Expert Rev Anticancer Ther. 2014 Oct;14(10):1141-52. doi: 10.1586/14737140.2014.940326. Epub 2014 Jul 28. Expert Rev Anticancer Ther. 2014. PMID: 25066490 Review.
-
Cyberknife radiosurgery for metastatic spine tumors.Neurosurg Clin N Am. 2004 Oct;15(4):491-501. doi: 10.1016/j.nec.2004.04.013. Neurosurg Clin N Am. 2004. PMID: 15450884 Review.
Cited by
-
Systematic Review of the Role of Stereotactic Radiotherapy for Bone Metastases.J Natl Cancer Inst. 2019 Oct 1;111(10):1023-1032. doi: 10.1093/jnci/djz101. J Natl Cancer Inst. 2019. PMID: 31119273 Free PMC article.
-
Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases.Contemp Oncol (Pozn). 2015;19(4):327-32. doi: 10.5114/wo.2015.53371. Epub 2015 Aug 7. Contemp Oncol (Pozn). 2015. PMID: 26557782 Free PMC article.
-
Stereotactic radiosurgery for spinal metastases: a literature review.Einstein (Sao Paulo). 2013 Apr-Jun;11(2):247-55. doi: 10.1590/s1679-45082013000200020. Einstein (Sao Paulo). 2013. PMID: 23843070 Free PMC article. Review.
-
Stereotactic body radiotherapy for treatment of spinal metastasis: A systematic review of the literature.Neurooncol Adv. 2024 Feb 13;6(Suppl 3):iii28-iii47. doi: 10.1093/noajnl/vdad175. eCollection 2024 Oct. Neurooncol Adv. 2024. PMID: 39430390 Free PMC article. Review.
-
Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.Cancer Med. 2019 Oct;8(14):6176-6184. doi: 10.1002/cam4.2546. Epub 2019 Sep 5. Cancer Med. 2019. PMID: 31489788 Free PMC article.
References
-
- Arcangeli G, Giovinazzo G, Saracino B, D'Angelo L, Giannarelli D, Micheli A. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys. 1998;42(5):1119–1126. - PubMed
-
- Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC. et al.Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol. 2005;23(15):3366–3375. - PubMed
-
- Baba F, Shibamoto Y, Tomita N, Ikeya-Hashizume C, Oda K, Ayakawa S, Ogino H, Sugie C. Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results. Radiat Oncol. 2009;4:15. - PMC - PubMed
-
- Hurkmans CW, Cuijpers JP, Lagerwaard FJ, Widder J, van der Heide UA, Schuring D, Senan S. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol. 2009;4:1. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources